TO

Translational Oncology

Translational Oncology publishes novel research investigations that bridge laboratory and clinical settings, including risk assessment, cellular and molecular characterization, prevention, detection, diagnosis, and treatment of human cancers, with the goal of improving clinical care for oncology patients.

Looking to publish in Translational Oncology? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.

Existing customer login
Subject Oncology
Impact Factor 4.1
Quartile Q2
Open Access Type Open
ISSN 1936-5233
eISSN 1936-5233
Invitation Only No
Cost Range Article Publishing Charge: USD 3880 excluding taxes.

Submission Instructions

Translational Oncology accepts the following article types. Click on an article type to view submission instructions.

Original Research Article

Cover Letter A cover letter is required. The cover letter must be on official letterhead with the author's institution logo and must not include funding information, author declarations, or suggested or opposed reviewers.
Abstract An abstract is required. Abstract must not exceed 250 words. Structured.
Manuscript Manuscript must not exceed 4,500 words. The manuscript must be divided into Introduction, Materials and Methods, Results, and Discussion. Keywords must be provided, and the declarations tool must be completed with any required generative AI disclosure.
References No more than 50 references may be included. References cited in the article must appear in the reference list, references in the reference list must be cited in the article, and references cited in the abstract must be given in full.
Figures & Tables No more than 6 figures and/or tables should be included. Figures and other graphical media must be supplied as separate files, and tables must be submitted as editable text. Tables, footnotes, and captions must be included in the submitted files.
Reformat to Translational Oncology using Livewrite Premium

Review Article

Cover Letter Cover Letter requirements are not specified.
Abstract Required. The abstract must not exceed 250 words. Unstructured.
Manuscript The manuscript must not exceed 4,500 words. The manuscript should include an introduction, discussion, and conclusion. Up to 5 authors are allowed without prior agreement of the editors.
References No more than 80 references may be included. Any references cited in the article must appear in the reference list, and any references listed must be cited in the article.
Figures & Tables No more than 6 figures and/or tables may be included.
Reformat to Translational Oncology using Livewrite Premium

Letters To The Editors

Cover Letter A cover letter is required. The cover letter must be on official letterhead with the logo from the author's institution.
Abstract An abstract must not be included.
Manuscript The manuscript must not exceed 1,000 words. The manuscript should be divided into clearly defined sections using headings. The manuscript should include keywords, acknowledgements in a separate section before the references, and a generative AI disclosure if applicable.
References No more than 10 references may be included. Any references cited in the article must appear in the reference list and references cited in the abstract must be given in full.
Figures & Tables No more than 1 figure and/or table may be included. Figures and tables must be supplied with the manuscript, and tables must be submitted as editable text rather than images. Tables, footnotes, and captions must be included in the submitted files.
Reformat to Translational Oncology using Livewrite Premium

Recent Publications

Programmed death 1 antibody drug conjugates (PD 1 ADCs): Innovations in overcoming resistance and enhancing immune mediated antitumor activity

Zilong Tian

10.1016/j.tranon.2026.102830
View Publication

Telomerase-related gene EHHADH drives lung cancer progression and shapes the immunosuppressive tumor microenvironment

Wei Wei, Yuheng Wang, Diliyaer Abudukeremu, Jinhua Luo, Mingjun Du

10.1016/j.tranon.2026.102852
View Publication

Bibliometric and visual analysis: A comprehensive tracking of global research trends on ablation and tumor immune microenvironment from 2016 to 2025

Sibo Meng, Jiaxin Li, Fangli Cao, Hongxin Niu

10.1016/j.tranon.2026.102855
View Publication

TFF1-mediated suppression of the TCA cycle promotes bone metastasis in triple-negative breast cancer

Hanshen Chen, Yiping Xu, Yixuan Liu, Yijie Tang, Jiapeng Qiu, Luyao Lei, Peicheng Lin, Yiran Chen, Xiaodan Wu

10.1016/j.tranon.2026.102846
View Publication

The PI3K/AKT signaling networks in cancer glucose metabolism: mechanisms and therapeutic implications

Sufen Cheng, Qi Jiang, Hua Huang, Hongyan Tong, Mixue Xie

10.1016/j.tranon.2026.102850
View Publication

Frequently asked questions

How long does it take to publish?

Proof corrections are requested within two days. The journal also uses single anonymized peer review with a minimum of two reviewers for suitable submissions.

Reformat to Translational Oncology using Livewrite Premium

Is a cover letter required?

A cover letter should be included with submission. It should be on official institutional letterhead, be short and focused, and should not include funding information, author declarations, or suggested or opposed reviewers.

Reformat to Translational Oncology using Livewrite Premium

What are the publication costs?

Open access journal with no subscription charges; an Article Publishing Charge of USD 3880 excluding taxes is payable for all articles.

Reformat to Translational Oncology using Livewrite Premium

Research Topics

Cancer Immunotherapy and Biomarkers Ferroptosis and cancer prognosis Cancer Cells and Metastasis Cancer-related molecular mechanisms research Cancer, Hypoxia, and Metabolism RNA modifications and cancer MicroRNA in disease regulation Cancer Genomics and Diagnostics Lung Cancer Treatments and Mutations Immunotherapy and Immune Responses Pancreatic and Hepatic Oncology Research Immune cells in cancer Epigenetics and DNA Methylation Radiomics and Machine Learning in Medical Imaging Glioma Diagnosis and Treatment Circular RNAs in diseases Immune Cell Function and Interaction Cancer-related Molecular Pathways Cancer, Lipids, and Metabolism Ubiquitin and proteasome pathways Lung Cancer Research Studies CAR-T cell therapy research MRI in cancer diagnosis Head and Neck Cancer Studies Extracellular vesicles in disease

Related Journals

PI
Progress in Neurobiology Elsevier BV
JO
Journal of Pharmaceutical Analysis Elsevier BV
EH
Experimental Hematology and Oncology BioMed Central
JO
Journal of Endodontics Elsevier BV
ME
Marine Environmental Research Elsevier BV
SJ
Spanish Journal of Psychiatry and Mental Health Elsevier BV